| Ytd | -28.16% | |
| 1y | -5.03% |
| Open | 21.30 | Prev Close | 21.43 | Low | 21.10 | High | 22.16 | Mkt Cap | 1.15B |
| Vol | 1.53M | Avg Vol | 1.29M | EPS | -1.60 | P/E | N/A | Forward P/E | -9.42 |
| Beta | 3.37 | Short Ratio | 7.49 | Inst. Own | 95.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 17.50 | 200-d Avg | 16.29 | 1yr Est | 22.40 |
BBNX News
New class action for Beta Bionics (BBNX) urges investors to seek recovery for alleged securities fra
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
Beta Bionics, Inc. (NASDAQ: BBNX - Get Free Report) insider Mike Mensinger sold 2,650 shares of the
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of L
NEW ORLEANS, Sept. 18, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, rem
SAN DIEGO--(BUSINESS WIRE)---- $BBNX #BetaBionics--Shareholder rights law firm Robbins LLP reminds i
San Francisco, California--(Newsfile Corp. - September 18, 2026) - Beta Bionics, Inc. (NASDAQ: BBNX)
NEW YORK, Sept. 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, rem
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces th
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
Boston, Massachusetts--(Newsfile Corp. - September 18, 2026) - Block & Leviton announces that a secu
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP
SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities c
IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced
New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces th
LOS ANGELES, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors
BBNX's FDA-cleared Mint patch pump expands its diabetes portfolio, with a full U.S. launch planned f
NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,
Time-sensitive notice: the lawsuit asserts that Beta Bionics management described an FDA Form 483 an
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has bee
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
Beta Bionics (BBNX) is evolving into a multi-product, platform-driven diabetes franchise with the FD
Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volu
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Bet
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securiti
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP announces th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
New class action for Beta Bionics (BBNX) urges investors to seek recovery for alleged securities fra
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
Institutional and fiduciary holders of Beta Bionics stock absorbed a decline of roughly $23.09 per s
U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 100 points o
U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other st
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP
Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks poste
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced
NEW YORK CITY and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and
A federal securities class action lawsuit has been filed against Beta Bionics. Investors who lost mo
Beta Bionics, Inc. (NASDAQ:BBNX) today announced that it intends to offer and sell, in an underwritt
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
Promise versus reality: the lawsuit contends Beta Bionics promoted "superior clinical outcomes" for
Truist Securities analyst Richard Newitter reiterates Beta Bionics (NASDAQ:BBNX) with a Buy and r
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, I
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor
SAN DIEGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder-rights law firm, a